Sodium danshensu attenuates cerebral ischemia–reperfusion injury by targeting AKT1

The beneficial properties of Sodium Danshensu (SDSS) for controlling cerebral ischemia and reperfusion injury (CIRI) are elucidated here both in vivo and in vitro. SDSS administration significantly improved the viability of P12 cells, reduced lactate dehydrogenase (LDH) leakage, and decreased the ap...

Full description

Bibliographic Details
Main Authors: Qing Gao, Hao Deng, Zhengfei Yang, Qiuyue Yang, Yilin Zhang, Xiaopeng Yuan, Miao Zeng, Maojuan Guo, Wenyun Zeng, Xijuan Jiang, Bin Yu
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-09-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2022.946668/full

Similar Items